188 related articles for article (PubMed ID: 26059710)
21. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model.
Larsen K; Cheng C; Tempel D; Parker S; Yazdani S; den Dekker WK; Houtgraaf JH; de Jong R; Swager-ten Hoor S; Ligtenberg E; Hanson SR; Rowland S; Kolodgie F; Serruys PW; Virmani R; Duckers HJ
Eur Heart J; 2012 Jan; 33(1):120-8. PubMed ID: 21733913
[TBL] [Abstract][Full Text] [Related]
22. Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model.
Chang HK; Kim PH; Kim DW; Cho HM; Jeong MJ; Kim DH; Joung YK; Lim KS; Kim HB; Lim HC; Han DK; Hong YJ; Cho JY
Exp Mol Med; 2018 Sep; 50(9):1-14. PubMed ID: 30174328
[TBL] [Abstract][Full Text] [Related]
23. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
24. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density.
Nishino S; Sakuma M; Kanaya T; Nasuno T; Tokura M; Toyoda S; Abe S; Nakamura D; Tanaka K; Attizzani GF; Bezerra HG; Costa MA; Inoue T
Int J Cardiovasc Imaging; 2019 Nov; 35(11):1971-1978. PubMed ID: 31218524
[TBL] [Abstract][Full Text] [Related]
25. Endothelialization of sirolimus-eluting stents with slow and extended drug release in the porcine overstretch model.
Frey D; Billinger M; Meier P; Beslac O; Grossenbacher R; Hänni B; Hess OM
J Invasive Cardiol; 2008 Dec; 20(12):631-4. PubMed ID: 19057024
[TBL] [Abstract][Full Text] [Related]
26. The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro.
Kastl SP; Katsaros KM; Krychtiuk KA; Jägersberger G; Kaun C; Huber K; Wojta J; Speidl WS
PLoS One; 2020; 15(5):e0232483. PubMed ID: 32392256
[TBL] [Abstract][Full Text] [Related]
27. Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor.
Ma X; Hibbert B; Dhaliwal B; Seibert T; Chen YX; Zhao X; O'Brien ER
Cardiovasc Res; 2010 May; 86(2):338-45. PubMed ID: 20167573
[TBL] [Abstract][Full Text] [Related]
28. Five-year follow-up of the endothelial progenitor cell capturing stent versus the paxlitaxel-eluting stent in de novo coronary lesions with a high risk of coronary restenosis.
Woudstra P; Kalkman DN; Beijk MA; Klomp M; Damman P; Koch KT; Henriques JPS; Baan J; Vis MM; Piek JJ; Tijssen JGP; de Winter RJ
Catheter Cardiovasc Interv; 2018 Jun; 91(7):1212-1218. PubMed ID: 28868810
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of neointimal formation with netrin-1 and netrin-1 preconditioned endothelial progenitor cells.
Liu NM; Siu KL; Youn JY; Cai H
J Mol Med (Berl); 2017 Mar; 95(3):335-348. PubMed ID: 28004124
[TBL] [Abstract][Full Text] [Related]
30. Functionalization with a VEGFR2-binding antibody fragment leads to enhanced endothelialization of a cardiovascular stent in vitro and in vivo.
Wawrzyńska M; Kraskiewicz H; Paprocka M; Krawczenko A; Bielawska-Pohl A; Biały D; Roleder T; Wojakowski W; O'Connor IB; Duda M; Michal R; Wasyluk Ł; Plesch G; Podbielska H; Kopaczyńska M; Wall JG
J Biomed Mater Res B Appl Biomater; 2020 Jan; 108(1):213-224. PubMed ID: 30964600
[TBL] [Abstract][Full Text] [Related]
31. Surface modification of implanted cardiovascular metal stents: from antithrombosis and antirestenosis to endothelialization.
Zhang K; Liu T; Li JA; Chen JY; Wang J; Huang N
J Biomed Mater Res A; 2014 Feb; 102(2):588-609. PubMed ID: 23520056
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the very long term (>1 year) outcomes of drug-eluting stents for the treatment of bare-metal and drug-eluting stent restenosis.
Ribamar Costa J; Sousa AG; Moreira A; Alves da Costa R; Cano MN; Maldonado G; Campos Neto C; Jardim C; Pavanello R; Sousa JE
EuroIntervention; 2009 Sep; 5(4):448-53. PubMed ID: 19755332
[TBL] [Abstract][Full Text] [Related]
33. Ex vivo and preclinical assessment of an endothelial progenitor cell capturing bioengineered stent.
Yazdani SK; Kolodgie FD; Virmani R
Minerva Cardioangiol; 2012 Feb; 60(1):11-21. PubMed ID: 22322570
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
Almalla M; Pross V; Marx N; Hoffmann R
Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
[TBL] [Abstract][Full Text] [Related]
35. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
36. Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents.
van Beusekom HM; Sorop O; van den Heuvel M; Onuma Y; Duncker DJ; Danser AH; van der Giessen WJ
EuroIntervention; 2010 May; 6(1):117-25. PubMed ID: 20542807
[TBL] [Abstract][Full Text] [Related]
37. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
[TBL] [Abstract][Full Text] [Related]
38. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.
Li Y; Tellez A; Rousselle SD; Dillon KN; Garza JA; Barry C; Granada JF
Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810
[TBL] [Abstract][Full Text] [Related]
39. Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury.
Wu X; Yin T; Tian J; Tang C; Huang J; Zhao Y; Zhang X; Deng X; Fan Y; Yu D; Wang G
Regen Biomater; 2015 Jun; 2(2):87-96. PubMed ID: 26813006
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
